UNASTELLA Secures $22.2 Million in Latest Series B Funding Round

UNASTELLA secured $22.2 million in its latest Series B, adding another data point to the Healthcare & Life Sciences funding market.

UNASTELLA Raises $22.2 million in Funding

UNASTELLA is a Digital Health company focused on Advance Next-Generation Launch Vehicles.

Investors Behind the Funding

The round was backed by undisclosed investors. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

UNASTELLA operates in Healthcare & Life Sciences. UNASTELLA's Series B round shows investors are still backing digital health platforms with real scale narratives. At $22M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

Advance Next-Generation Launch Vehicles

Looking Ahead

UNASTELLA Closes $22.2M Series B Round to Advance Next-Generation Launch Vehicles

Source reference: original announcement/article.